Resources designed for your office
Here you will find several educational resources that outline treatment efficacy, safety, dosing, and more:
Educational materials for patients and caregivers
Discover supportive resources dedicated to patient and caregiver education:
Discover community and education for your patients
OHF: Oxalosis & Hyperoxaluria Foundation
OHF brings people together to advocate and advance toward a cure.
NORD: National Organization for Rare Disorders
NORD helps people battling rare disease feel seen, heard, supported, and connected.
AKF: American Kidney Fund
AKF provides life-saving financial assistance and life-changing educational resources for people impacted by kidney disease.
NKF: National Kidney Foundation
NKF provides education, resources, support, and advocacy for people living with kidney disease.
Have questions about Rivfloza®? Reach out to our team of representatives
Important Safety Information for Rivfloza®
Adverse Reactions
Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.
Indication and Usage
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Please click here for Rivfloza® Prescribing Information.
Important Safety Information for Rivfloza®
Adverse Reactions
Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.
Indication and Usage
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Please click here for Rivfloza® Prescribing Information.